- Home
- NPWR vs OBIO Comparison
NPWR vs OBIO Comparison
Compare NPWR & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPWR
- OBIO
- Stock Information
- Founded
- NPWR 2010
- OBIO 2017
- Country
- NPWR United States
- OBIO United States
- Employees
- NPWR N/A
- OBIO N/A
- Industry
- NPWR Industrial Machinery/Components
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- NPWR Energy
- OBIO Health Care
- Exchange
- NPWR Nasdaq
- OBIO Nasdaq
- Market Cap
- NPWR 171.3M
- OBIO 146.2M
- IPO Year
- NPWR N/A
- OBIO N/A
- Fundamental
- Price
- NPWR $3.56
- OBIO $2.70
- Analyst Decision
- NPWR Buy
- OBIO Strong Buy
- Analyst Count
- NPWR 2
- OBIO 4
- Target Price
- NPWR $4.00
- OBIO $14.00
- AVG Volume (30 Days)
- NPWR 1.3M
- OBIO 222.4K
- Earning Date
- NPWR 11-10-2025
- OBIO 11-11-2025
- Dividend Yield
- NPWR N/A
- OBIO N/A
- EPS Growth
- NPWR N/A
- OBIO N/A
- EPS
- NPWR N/A
- OBIO N/A
- Revenue
- NPWR $12,000.00
- OBIO $2,944,000.00
- Revenue This Year
- NPWR N/A
- OBIO $29.26
- Revenue Next Year
- NPWR N/A
- OBIO $10.65
- P/E Ratio
- NPWR N/A
- OBIO N/A
- Revenue Growth
- NPWR N/A
- OBIO 41.61
- 52 Week Low
- NPWR $1.48
- OBIO $2.20
- 52 Week High
- NPWR $14.28
- OBIO $6.50
- Technical
- Relative Strength Index (RSI)
- NPWR 68.86
- OBIO 55.64
- Support Level
- NPWR $2.94
- OBIO $2.20
- Resistance Level
- NPWR $3.87
- OBIO $2.89
- Average True Range (ATR)
- NPWR 0.32
- OBIO 0.14
- MACD
- NPWR 0.10
- OBIO 0.04
- Stochastic Oscillator
- NPWR 81.25
- OBIO 74.45
About NPWR NET Power Inc.
NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.